A detailed history of Mc Ilrath & Eck, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 7,107 shares of PFE stock, worth $186,487. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,107
Previous 7,003 1.49%
Holding current value
$186,487
Previous $194,000 2.06%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $2,627 - $3,078
104 Added 1.49%
7,107 $198,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $9,165 - $10,524
-354 Reduced 4.81%
7,003 $194,000
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $9,380 - $12,184
-359 Reduced 4.65%
7,357 $211,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $19,286 - $22,543
-601 Reduced 7.23%
7,716 $255,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $34,855 - $40,327
-965 Reduced 10.4%
8,317 $305,000
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $46,913 - $61,074
1,191 Added 14.72%
9,282 $378,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $22,962 - $29,975
550 Added 7.29%
8,091 $414,000
Q3 2022

Oct 18, 2022

SELL
$43.76 - $53.42 $11,858 - $14,476
-271 Reduced 3.47%
7,541 $330,000
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $35,269 - $41,818
758 Added 10.75%
7,812 $410,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $45 - $56
1 Added 0.01%
7,054 $365,000
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $21,321 - $31,605
-516 Reduced 6.82%
7,053 $416,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $2,315 - $2,974
59 Added 0.79%
7,569 $326,000
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $7,289 - $8,258
-203 Reduced 2.63%
7,510 $294,000
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $6,262 - $7,062
-187 Reduced 2.37%
7,713 $279,000
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $57,501 - $73,118
1,718 Added 27.79%
7,900 $291,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $42,513 - $49,877
1,339 Added 27.65%
6,182 $227,000
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $30,692 - $37,234
1,019 Added 26.65%
4,843 $158,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $3,000 - $4,286
-111 Reduced 2.82%
3,824 $125,000
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $13,991 - $15,878
425 Added 12.11%
3,935 $154,000
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $14,263 - $18,495
-439 Reduced 11.12%
3,510 $126,000
Q1 2019

May 07, 2019

BUY
$37.5 - $41.2 $37,612 - $41,323
1,003 Added 34.05%
3,949 $168,000
Q4 2018

May 07, 2019

BUY
$38.47 - $43.86 $6,847 - $7,807
178 Added 6.43%
2,946 $129,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $12,719 - $15,427
369 Added 15.38%
2,768 $122,000
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $1,055 - $1,125
32 Added 1.35%
2,399 $87,000
Q1 2018

May 22, 2018

SELL
$31.91 - $37.02 $90,720 - $105,247
-2,843 Reduced 54.57%
2,367 $84,000
Q4 2017

Mar 19, 2018

BUY
$33.26 - $35.29 $173,284 - $183,860
5,210
5,210 $189,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mc Ilrath & Eck, LLC Portfolio

Follow Mc Ilrath & Eck, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.